Investigating the Safety and Performance of SenSura Test Product in Subjects With Ileostomy
Not Applicable
Completed
- Conditions
- Stoma Ileostomy
- Interventions
- Device: SenSuraDevice: SenSura test product
- Registration Number
- NCT02887144
- Lead Sponsor
- Coloplast A/S
- Brief Summary
The aim of the current Investigation is to evaluate the safety and performance of SenSura test product 1pc flat and convex light compared with commercial SenSura.
- Detailed Description
Investigators want to measure degree of leakage on a 4-point scale of SenSura and SenSura test product.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 72
Inclusion Criteria
- Have given written informed consent
- Be at least 18 years of age and have full legal capacity
- Be able to handle the products themselves
- Have an ileostomy (end or loop ostomy) with a diameter between 10 - 40 mm
- Have had their ileostomy for at least 3 months
- Have used a 1-piece flat or convex light ostomy appliance with an open bag within the last month
- Currently using midi or maxi bags
- Willing to use minimum 1 product every second day (max. 2 days wear time)
- Be mentally and physically capable of understanding and following the study procedures and completing the Case Report Form
- Must be able to cut products themselves
Exclusion Criteria
- Currently receiving or have received within the past 2 months chemo- or/and radiation therapy
- Currently receiving or have received within the past month local or systemic steroid treatment in the peristomal area
- Are pregnant or breastfeeding
- Participating in other interventional clinical investigations or have previously participated in this investigation
- Currently suffering from peristomal skin problems (i.e. bleeding or broken skin).
- Known hypersensitivity of the product components and/or ingredients
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description SenSura 1pc SenSura test product Subjects randomized to treatment sequence 2 test: 1. SenSura 2. SunSura test product SenSura test product 1pc SenSura Subjects randomized to treatment sequence 1test: 1. SenSura test product 2. SenSura SenSura test product 1pc SenSura test product Subjects randomized to treatment sequence 1test: 1. SenSura test product 2. SenSura SenSura 1pc SenSura Subjects randomized to treatment sequence 2 test: 1. SenSura 2. SunSura test product
- Primary Outcome Measures
Name Time Method Degree of leakage patients will test the products for 4 weeks Leakage under and outside the baseplate will be assessed by a 4 point leakage scale.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Coloplast A/S
🇩🇰Humlebaek, Denmark